Scholar Rock Says FDA Review Of Apitegromab BLA Continues; Approval Decision Expected By Sept. 30 | 08.08.26 | finanzen.ch
(RTTNews) - Scholar Rock Holding Corp. (SRRK) said Friday the U.S. Food and Drug Administration will continue reviewing the Biologics License Appl...
Videos
Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio
21 Minuten 10 Sekunden
